The Department of Energy and the Weill Family Foundation on Monday signed a memorandum of understanding for a new public-private partnership which will use the agency’s artificial intelligence capabilities for biomedical research. Former Citigroup CEO Sandy Weill and Energy Secretary Rick Perry told CNBC’s “Closing Bell ” in an exclusive interview that the partnership aims… Read More »
Ilya Cantor joins as Chief Financial Officer August 15, 2019, Cupertino, California: Mobileum Inc. (Mobileum), a leading global provider of analytics-based roaming and risk management solutions for global communications service providers (CSPs), today announced the appointment of Ilya Cantor as its new Chief Financial Officer. With two-plus decades of experience at multinational public and private… Read More »
Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »
Print this page DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for Ravicti (glycerol phenylbutyrate) Oral Liquid to include infants younger than two months of age living with a urea cycle disorder… Read More »
Print this page CORALVILLE, Iowa, Jan. 07, 2019 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for two additional strengths of Apadaz, an immediate release (IR)… Read More »